Obesity may act through a variety of cancer-promoting pathways, such as chronic insulin resistance, hyperinsulinemia and increased activity of insulin-like growth factor (IGF)-I [52]. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.